Delivery Order SPE2DB22D2211-SPE2DB25FSDKV
- Not listed
- The Defense Logistics Agency (DLA) awarded a $28,225.08 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $4,429.98 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,443.00 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) with a firm fixed price structure. The contract is unclassified with no set-aside designation and was competitively awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,689.70 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide ROTARIX vaccine oral syringes. The contract has a completion date of January 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and is based in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $8,212.02, with a completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.68 to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with an ultimate completion date of August 14, 2025. The award was made on August 13, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Rotarix Vaccine Oral Syringes in Conshohocken, Pennsylvania. The firm fixed price contract has a potential value of $34,064.40 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds multiple federal contracts, including an Indefinite Delivery Contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency awarded a $12,327.80 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDKVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,684.64 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5mL) on August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance, with an ultimate completion date of August 25, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts predominantly with the DLA and its Medical Supply Chain. The company's federal contracting demonstrates significant capability to meet federal procurement requirements across a wide spectrum of pharmaceutical products including vaccines, medications, medical devices, and specialized healthcare commodities. This delivery order for Rotarix vaccine reflects the company's ongoing role in supporting military and veteran healthcare systems through the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 8/22/25 |